Evidence map›Paper›PMID 37202218›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2023

Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).

Pantelis A Sarafidis, Marieta Theodorakopoulou, Alberto Ortiz, Beatriz Fernandez-Fernández, Ionut Nistor, Roland Schmieder, Mustafa Arici, Athanasios Saratzis, Patricia Van der Niepen, Jean-Michel Halimi and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Guideline
  3. Article
  4. Contemporary Trends in Disparities for Renal Artery Stenting and Angioplasty in the United States.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. CT angiography of acute aortic syndrome in patients with chronic kidney disease.The international journal of cardiovascular imaging · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 10 countries.

Pantelis A SarafidisDepartment of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID 0000-0002-9174-4018
Marieta TheodorakopoulouDepartment of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID 0000-0001-6216-9635
Alberto OrtizDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.ORCID 0000-0002-9805-9523
Beatriz Fernandez-FernándezDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.
Ionut NistorDepartment of Internal Medicine, Nephrology and Geriatrics, Grigore T Popa University of Medicine and Pharmacy, Iasi, Romania.
Roland SchmiederDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.
Mustafa AriciDepartment of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Athanasios SaratzisDepartment of Cardiovascular Sciences & Leicester Vascular Institute, University Hospital Leicester, Leicester, UK.
Patricia Van der NiepenDepartment of Nephrology & Hypertension, Universitair ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-6401-1580
Jean-Michel HalimiService de Néphrologie-Hypertension, Dialyses, Transplantation rénale, CHRU Tours, Tours, France and INSERM SPHERE U1246, Université Tours, Université de Nantes, Tours, France.
Reinhold KreutzCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.
Andrzej JanuszewiczDepartment of Hypertension, National Institute of Cardiology, Warsaw, Poland.
Alexandre PersuDivision of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Mario CozzolinoRenal Division, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.ORCID 0000-0002-8494-6252
Aristotle University of Thessaloniki · GRHospital Universitario Fundación Jiménez Díaz · ESCharité - Universitätsmedizin Berlin · DECliniques Universitaires Saint-Luc · BEGrigore T. Popa University of Medicine and Pharmacy · ROHacettepe University · TRInstitute of Cardiology · PLLeicester General Hospital · GBUniversitätsklinikum Erlangen · DEUniversité de Tours · FRUniversity of Milan · ITVrije Universiteit Brussel · BE

Funding

European UnionFEDER PI20/00744Instituto de Salud Carlos III RD21/0005/0001
6 · The paper itself

Abstract

Atherosclerotic renovascular disease (ARVD) is the most common type of renal artery stenosis. It represents a common health problem with clinical presentations relevant to many medical specialties and carries a high risk for future cardiovascular and renal events, as well as overall mortality. The available evidence regarding the management of ARVD is conflicting. Randomized controlled trials failed to demonstrate superiority of percutaneous transluminal renal artery angioplasty (PTRA) with or without stenting in addition to standard medical therapy compared with medical therapy alone in lowering blood pressure levels or preventing adverse renal and cardiovascular outcomes in patients with ARVD, but they carried several limitations and met important criticism. Observational studies showed that PTRA is associated with future cardiorenal benefits in patients presenting with high-risk ARVD phenotypes (i.e. flash pulmonary oedema, resistant hypertension or rapid loss of kidney function). This clinical practice document, prepared by experts from the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and from the Working Group on Hypertension and the Kidney of the European Society of Hypertension (ESH), summarizes current knowledge in epidemiology, pathophysiology and diagnostic assessment of ARVD and presents, following a systematic literature review, key evidence relevant to treatment, with an aim to support clinicians in decision making and everyday management of patients with this condition.

Indexed as

AtherosclerosisHypertensionHypertension, RenovascularRenal Artery ObstructionAngioplastyHumansKidneyPractice Guidelines as Topicangioplastyatherosclerotic renovascular diseaseepidemiologyrenal artery stenosisrevascularization

Identifiers

PMID37202218
PMCPMC10689166
OpenAlexW4377012509

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.